Gain new perspectives for faster progress directly to your inbox.
![PRD1 bacteriophage, illustration. Molecular model of the structure of a PRD1 bacteriophage](/sites/default/files/styles/insights_index_hero/public/images/GettyImages-1328336212_CAS-Insights-Hero-Image.jpg?h=d1cb525d&itok=YQY1vdvZ)
PEGylation is a breakthrough technique to improve drug delivery systems, but it also has a downside: it can trigger immune reactions that reduce drug efficacy and safety. Designed for R&D leaders, this idea in brief shows how we can overcome this challenge. It summarizes the latest trends and opportunities, PEG-lipid structure, LNP composition and properties, and which pharmaceutical parameters affect their immunogenicity and efficiency. Learn more and share with your network: